| Award Title | Agency | Phase | Award amount | Start Date | End Date |
|---|---|---|---|---|---|
|
Novel beta-lactams as inhibitors of ebola virus infections
Microbiotix, Inc. Principal Investigator |
HHS | 1 | $304K | 06/24/16 | 05/31/17 |
|
Small Molecule Inhibitors of trans-Translation with Broad Spectrum Antibacterial
Microbiotix, Inc. Principal Investigator |
HHS | 1 | $295K | 07/01/15 | 06/30/16 |
|
Small Molecule Inhibitors of trans-Translation with Broad Spectrum Antibacterial
Microbiotix, Inc. Principal Investigator |
HHS | 1 | $296K | 07/07/14 | 06/30/15 |
|
Quinoline-based Inhibitors of BoNT/A LC
Microbiotix, Inc. Principal Investigator |
HHS | 1 | $294K | 04/01/12 | 03/31/13 |
|
Quinoline-based Inhibitors of BoNT/A LC
Microbiotix, Inc. Principal Investigator |
HHS | 1 | $300K | 04/01/11 | 03/31/12 |
|
Novel Inhibitors of Staphylococcal Biofilm Formation
Microbiotix, Inc. Principal Investigator |
HHS | 1 | $300K | 09/01/08 | 08/31/10 |
|
Novel Inhibitors of Staphylococcal Biofilm Formation
Microbiotix, Inc. Principal Investigator |
HHS | 1 | $193K | 09/01/07 | 08/31/08 |
